AVEO: More Open Questions Than Answers Seeking Alpha The activity in the patient population that was studied in Sutent's phase III trial (clear-cell histology and prior nephrectomy) was even more impressive - 14.8 months. (The Sutent study recruited only clear cell patients, 90% of them had had prior ... |
